Furthermore, ME1 overexpression or treatment with ME1 inhibitor abrogated circME1 silencing or overexpression-induced inhibition or promotion of glycolysis and glycolytic capacity of ccRCC cells (Supplementary Fig. S4E, F). The gene discussed is ME1; the disease is nonpapillary renal cell carcinoma.